The SAMSARA BIOCAPITAL is a privately held investment adviser that advises $2.17Bn in regulatory assets under management held in 1 SEC fund types across 1 investment strategies. SAMSARA BIOCAPITAL is a Private Fund A private fund manager is a manager whose >=75% of total assets under management are in private funds (privately offered pooled vehicles for accredited or qualified investors, generally accessed through placements with higher minimums, restricted eligibility, and negotiated terms) Manager. Assets increased by 123.15% over the last 5-years.
The Group has been registered with the SEC for 9.37 years and is comprised of 1 filing and 0 relying advisers. They operate out of 1 office location Out of Private Residence. The Group has not been subject to regulatory enforcement actions. They are regulated by 1 US and Non-US bodies.
They have 31 employees comprised of 22 investment and 9 non-investment staff. The total number of Employees increased by 63.16% over the last 5-years.
Their $2.17Bn in assets advised are owned by 3 private funds, 0 public funds and BDCs and 0 other accounts. Assets of Pooled Investment Vehicles (Not IC or BDC) clients total $2.17Bn or 100% of Total Assets.
The Group's top investment strategies include Early Stage, representing 100% of total assets, respectively.
They advise 1 types of clients, top clients are Pooled Investment Vehicles (Not IC or BDC).
The Group uses 1 Fund Administrators, 1 Fund Auditors, 3 Prime Brokers, 2 Custodians and 0 Marketers. It does not report a third-party Fund Administrator in 1 private funds with $0 in assets.
The Group discloses management fees and performance-based fees.
SAMSARA BIOCAPITAL names 0 sub-advisers to 0 different funds advised by the group. The Group has been named as the sub-adviser to 0 funds.